{Reference Type}: Journal Article
{Title}: Current regulatory status in China of drugs withdrawn from the US FDA accelerated pathway: implications for regulation globally.
{Author}: Luo X;Huang L;Du X;Yang Y;Lv X;Zhang X;
{Journal}: Lancet Oncol
{Volume}: 25
{Issue}: 6
{Year}: 2024 Jun
{Factor}: 54.433
{DOI}: 10.1016/S1470-2045(24)00025-1